The Global Intraosseous Devices Market can be segmented into Latin America, Europe, North America, Asia Pacific, and the Middle East & Africa in terms of region. North America is likely to dominate the global intraosseous devices market during the projected period owing to the stringent guidelines implemented by the American Heart Association (AHA) and other organizations, besides product launch.
Browse Complete Report Details:
The need for intravascular access in adult traumatic patients are escalating the demand for infusion devices finds, Fortune Business Insights in a report, titled “Intraosseous Devices Market Size, Share and Global Trend By Device Type(Manual Semi-automated, Automated), By Location (Sternum, Distal Femur, Distal & Proximal Tibia, Calcaneus, Head of Humerus, Non-viral vectors), By Age Group (Adults, Pediatrics), By End-User(Hospital, Emergency Medicine, Ambulatory Surgical Centers, Specialty Clinics, Trauma Centers Geography Forecast till 2026”. Product innovations are positively impacting the global Intraosseous devices market predicts, Fortune Business Insights
Some of the Main Key Players Covered in the Report
- PerSys Medical
- Cook Medical
- Teleflex Incorporated
- Aero Healthcare
- Becton Dickinson and Company
- PAVmed Inc.
Venous Access Failure in Favor of the Growth of the Global Intraosseous Device Market
The acceptance of intraosseous infusion devices among patients and medical practitioners, owing to numerous benefits during emergencies is predicted to drive the intraosseous devices market. In addition, rising per capita income and growing inclination towards spending on advanced treatment is likely to fuel demand for intraosseous infusion devices in the forthcoming year. The intraosseous infusion devices are utilized at the time of venous access failure for cardiopulmonary resuscitation.
The rising incidence of life-threatening diseases and traumatic injuries and subsequently rising demand for immediate fluid resuscitation are some of the factors that are expected to favor the growth of the global intraosseous infusion market over the forecast period. The use of FASTTactical, a new device launched specially for military and hospital critical care teams, is likely to support the Global Intraosseous Market. The escalating number of traumatic surgeries in medical centers and the rising prevalence of cardiovascular disorders are predicted to further boost market growth.
Nevertheless, The complexity associated with the use of intraosseous devices such as extravasation of fluids and medications into the soft tissue and fractures may lead to osteomyelitis, which is predicted to inhibit the growth in intraosseous devices market.
Sample PDF Brochure:
Tactical Combat Casualty Care (TCCC) Will Exhibit The Highest Demand For Intraosseous Devices
Primarily, intraosseous devices were used in pediatric emergencies needing urgent vascular access. In 2005, the American Heart Association (AHA) and the European Resuscitation Council (ERC) approved the use intraosseous infusion devices for the treatment of cardiac arrest in adults, and even during emergencies especially when there is no availability of IV access.
United States of America Army committee along with Tactical Combat Causality Care (TCCC) supports and recommends the use of intraosseous infusion devices in any resuscitation case in which IV access is not attainable. The use of manual needles introduced the first intraosseous infusion device, which is still comprehensively employed by several medical practitioners. The intraosseous needles are commercially available with several different manuals.
Rapid incidence of various diseases and emergency cases, such as trauma, cardiac arrest, and rising military activities have fueled the demand for intraosseous devices. These factors are likely to aid in the expansion of global intraosseous devices market in the forthcoming year. In addition, Investment in research and development by key companies is also predicted to drive the intraosseous device market.
North America Expected To Lead The Global Intraosseous Devices Market
For instance, in 2019, PAVmed Inc. announced that PortIO Intraosseous Infusion System, an implantable intraosseous device under investigation, achieved maintenance-free successful implant period of around 60 days in pre-clinical animal testing.
The expected marketing clearance of the product by the FDA is anticipated to accelerate the growth rate of the global intraosseous devices market in North America. In Europe and the Asia Pacific, the intraosseous devices market is estimated to expand in the forecast duration owing to the rising number of cardiac diseases and emergency visits to hospitals.
Some of the major companies that are present in the global intraosseous devices market are PerSys Medical, Cook, Pyng Medical, Teleflex Incorporated, Aero Healthcare AU Pty Ltd., Becton, Dickinson and Company, PAVmed Inc., and other players.
More Trending Topics from Future Business Insights: